 Notes from the East Woods musings on opportunities in the life science marketplace April 2011
|
|
|
| Greetings! |
Getting the most out of your creations is not a simple path. Here we look to the windmills for ideas. Please have a read and feel free to let me know what you think.
Also if you missed some of our earlier Notes, you can view them all here.
Regards,
Paul Danis Founder and Principal
|
|
|
|
|
|
| Windmill Revenue |

It amazes me that the windmills over in Princeton have never stopped turning. Every time I gaze across the Wachusett Reservoir to the ridge in Princeton, the big white blades are lazily spinning. Maybe they do stop once in a while, but I've never seen it. Many companies would love this type of business - at all hours of the day the cash keeps rolling in. This is a conundrum for companies, large and small, that are developing new products. How do you maximize the revenue that can be obtained from the innovative products coming out from behind the curtain? Many look to the windmill model where they first sell a piece of equipment then watch as the revenue rolls in from the consumption of the bits and pieces needed to keep it operating. This works great if the measurements or tests are all the same, the thousands of samples are the same type, and the operator does not need 3 PhD's. However, many companies making equipment are relying on the customers to be the experts and develop their own custom methods. This case is more like the windmill manufacturers that sell 3 million dollar windmills to towns like Princeton. A long sales cycle, a big sale, then start a new sales cycle again - kinda lumpy. To smooth this out, others look to leveraging their technologies to offer a service to their customers. Many companies consider this as an easy add-on to their current businesses. Just look at how many instrument vendors now have service arms ( Bruker, Caliper, Beckman, Millipore to name a few) Another approach to harvesting your innovations is to collaborate to create valuable biological discoveries. This is a riskier approach with longer payback, but has worked for some folks with unique platforms such as BG Medicine and Rules Based Medicine. A final pathway is to take your research technology and move it downstream to a production environment or a diagnostic facility. Both have much more stringent requirements than the RUO (research use only) world. But once inserted into a process or accepted as a routine test, the revenue flows quite nicely. So when you are looking to get the most from your innovations, be sure to look beyond just selling a cool new box. Like the windmills in Princeton, consider the various ways to bring your value to the market, and you too may be able to generate energy ($$) day and night.
|
Life Science Market Update
|
|
Index
|
Mar Value
|
Change 12mo.
|
12 mo. High
|
12 mo. Low
| |
EC BioTool
|
878
|
24%
|
878
|
609
| |
EC BigPharma
|
807
|
1%
|
818
|
696
| |
EC Biotech
|
729
|
15%
|
729
|
523
|
BioTools and BigPharma were relatively mixed this month with changes of only a few percent either way. Biotech, on the other hand, had a dynamic month, up 8% from February's close. Winners were InterMune up 29% on EU approval to market its drug Esbriet for adults with pulmonary fibrosis, and Cephalon up 35% on a hostile takeover bid from Valeant Pharmaceuticals. Amylin Pharmaceuticals was the big loser down 26% on results from a study showing their diabetes drug Bydureon was less effective than Novo Nordisk's Victoza.
EC BioIndex March 2011
---------------------
Many of the life science indices currently available are a mixture of various types of companies. In order to better assess the situation in the different segments, Eastwoods Consulting has created these price-weighted indices for the sectors of large pharmaceutical companies, biotech companies, and life science research tools companies.
- EC BioTools Index - A, ACCL, AFFX, BEC, BIO, BRKR, CALP, DNEX, HBIO, HLCS, ILMN, LIFE, LMNX, PKI, QGEN, SIAL, TECH, TMO, WAT
- EC BigPharma Index - JNJ, PFE, GSK, NVS, SNY, LUN, ABT, LLY, AZN, WYE, BMY, NVO, BAX, TEVA, KG, ROG.VX
- EB Biotech Index - AMGN, GENZ, BIIB, CEPH, GILD, BMRN, AMLN, IDXX, ITMN, SEPR, PDLI, CPHD, ALKS, REGN, VRTX, THRX, HGSI, SGMO, NKTR
- Prices are taken at the close of each month.
|
|
| About Eastwoods Consulting
|
Translating Innovations into Profits for the Life Science IndustrysmEastwoods Consulting helps life science companies grow their businesses. Please visit our web site or contact us to learn more about how we help companies succeed in competitive markets.
|
Copyright © 2011, Eastwoods Consulting. This publication may be freely redistributed in full or in part as long as full attribution including our contact information and web address, are included. Eastwoods is a registered servicemark of Eastwoods Consultng.
|
|
|
|
|